These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10578298)
1. Dose- and time-related acceleration of chronic graft vascular disease caused by cyclosporine in a rat cardiac isograft model. Teranishi K; Usui A; Maseki T; Watanabe T; Yasuura K; Imaizumi M Transplant Proc; 1999 Nov; 31(7):2801-3. PubMed ID: 10578298 [No Abstract] [Full Text] [Related]
2. Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model. Teranishi K; Poston RS; Tsao PS; Asagami T; Cooke JP; Reitz BA; Robbins RC Transplant Proc; 1998 Jun; 30(4):1012-3. PubMed ID: 9636409 [No Abstract] [Full Text] [Related]
3. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats. Hisatomi K Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378 [No Abstract] [Full Text] [Related]
4. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation. Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960 [No Abstract] [Full Text] [Related]
5. Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model. Teranishi K; Usui A; Maseki T; Watanabe T; Yasuura K; Imaizumi M Transplant Proc; 1999 Nov; 31(7):2772-4. PubMed ID: 10578286 [No Abstract] [Full Text] [Related]
6. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation. Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130 [No Abstract] [Full Text] [Related]
7. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
9. Effect of a new immunosuppressive agent, KF20444, in rat cardiac transplantation. Nomura M; Yamashita K; Takehara M; Omura T; Nakajima H; Kishida A; Furukawa H; Todo S Transplant Proc; 1999; 31(1-2):1206-7. PubMed ID: 10083539 [No Abstract] [Full Text] [Related]
10. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model. Little DM; Stoltenberg RL; Hullett DA; Sollinger HW Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445 [No Abstract] [Full Text] [Related]
11. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats. Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900 [No Abstract] [Full Text] [Related]
12. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
13. Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model. Teranishi K; Poston RS; Reitz BA; Robbins RC Transplant Proc; 1998 Jun; 30(4):1009-11. PubMed ID: 9636408 [No Abstract] [Full Text] [Related]
14. Inhibition of graft coronary arteriosclerosis after heart transplantation. Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833 [TBL] [Abstract][Full Text] [Related]
16. Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506. Fujimura T; Yang XF; Soriano R; Ogawa T; Kobayashi M; Jiang H Transplant Proc; 1998 Jun; 30(4):1023-6. PubMed ID: 9636413 [No Abstract] [Full Text] [Related]
17. Effect of cyclosporine on chronic vascular rejection in an inbred rat cardiac model. Forbes RD; Gomersall M; Guttmann RD Transplant Proc; 1993 Feb; 25(1 Pt 1):530-1. PubMed ID: 8438402 [No Abstract] [Full Text] [Related]
18. The effects of heart/kidney versus double heart transplantation on tolerance induction and prevention of cardiac allograft vasculopathy. Yamada K; Menard MT; Mawulawde K; Slisz JK; Choo JK; Erhorn AE; Sachs DH; Madsen JC Transplant Proc; 1999; 31(1-2):108. PubMed ID: 10083032 [No Abstract] [Full Text] [Related]
19. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response. Maggard MA; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski JW; Busuttil RW; Imagawa DK Transplant Proc; 1999; 31(1-2):728-9. PubMed ID: 10083311 [No Abstract] [Full Text] [Related]
20. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart. Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H Transplant Proc; 1999; 31(1-2):143-6. PubMed ID: 10083050 [No Abstract] [Full Text] [Related] [Next] [New Search]